Continuity of care for patients with chronic lymphocytic leukemia: an analysis of real-world data
Greater CoC was significantly associated with reduced ER visits and reduced hospitalization, among patients diagnosed with CLL who received cBTKi therapy. While interpretation may be limited in the retrospective design, sensitivity and post-hoc analyses support this relationship. The findings from this study suggest the importance of maintaining a consistent oncologist/hematologist for the patient with CLL to reduce these healthcare events; however, causality cannot be inferred from this study.
Authors
- Lisa M. Hess (ORCID: https://orcid.org/0000-0003-3631-3941)
- Naleen Raj Bhandari (ORCID: https://orcid.org/0000-0002-4452-8021)
- Yongmei Chen (ORCID: https://orcid.org/0000-0003-2246-0916)
- Sameh Gabella
- Sarang Abhyankar
- Manoj Khanal (ORCID: https://orcid.org/0000-0002-3729-3666)
- Katherine B. Winfree (ORCID: https://orcid.org/0000-0003-2088-1004)
Institutions
- Eli Lilly (United States) (US)
- Moffitt Cancer Center (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1080/13696998.2025.2554514
- Citations
- 1
- Primary Topic
- Primary Care and Health Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.82